Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - Lab study shows sera from persons fully vaccinated with the Pfizer–BioNTech vaccine can effectively neutralize B.1.617 (Delta) and other SARS-CoV-2 variants.

Sté Tunisienne des Maladies Respiratoires et d'Allergologie

Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis

Lab study shows sera from persons fully vaccinated with the Pfizer–BioNTech vaccine can effectively neutralize B.1.617 (Delta) and other SARS-CoV-2 variants.

Zouhair Souissi

Bibliographie

14 juin 2021

Soyez le premier à commenter!

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants – Nature Commentary on Twitter An in-vitro study of sera from persons fully vaccinated with the Pfizer-BioNTech vaccine found that all samples neutralized SARS-CoV-2 virus variants B.1.617.1 (Kappa), B.1.617.2 (Delta), B.1.618 and B.1.525. https://t.co/7lXCVe7sPY — Carlos del Rio (@CarlosdelRio7) June 12, 2021

The post Lab study shows sera from persons fully vaccinated with the Pfizer–BioNTech vaccine can effectively neutralize B.1.617 (Delta) and other SARS-CoV-2 variants. appeared first on Links Medicus.

Lu 623 fois